End-of-day quote
Shanghai S.E.
06:00:00 2024-05-19 pm EDT
|
5-day change
|
1st Jan Change
|
7.07
CNY
|
-4.85%
|
|
-3.68%
|
-36.25%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,904
|
3,465
|
3,265
|
2,800
|
2,115
|
2,126
|
Enterprise Value (EV)
1 |
3,889
|
3,836
|
4,001
|
3,914
|
3,126
|
2,897
|
P/E ratio
|
38.8
x
|
30.2
x
|
56.8
x
|
-57
x
|
-13.9
x
|
-13.5
x
|
Yield
|
-
|
0.47%
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.96
x
|
1.89
x
|
1.54
x
|
1.08
x
|
0.92
x
|
1.06
x
|
EV / Revenue
|
2.95
x
|
2.1
x
|
1.88
x
|
1.51
x
|
1.35
x
|
1.44
x
|
EV / EBITDA
|
16
x
|
13.1
x
|
16.1
x
|
23.8
x
|
74.1
x
|
93.7
x
|
EV / FCF
|
-14.9
x
|
-26.8
x
|
-13.2
x
|
-20.9
x
|
13
x
|
7.5
x
|
FCF Yield
|
-6.7%
|
-3.74%
|
-7.6%
|
-4.77%
|
7.71%
|
13.3%
|
Price to Book
|
2.57
x
|
2.25
x
|
1.98
x
|
1.81
x
|
1.52
x
|
1.76
x
|
Nbr of stocks (in thousands)
|
205,144
|
205,144
|
198,224
|
194,602
|
191,621
|
191,725
|
Reference price
2 |
19.03
|
16.89
|
16.47
|
14.39
|
11.04
|
11.09
|
Announcement Date
|
4/25/19
|
4/29/20
|
4/29/21
|
4/25/22
|
4/26/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,317
|
1,831
|
2,125
|
2,600
|
2,309
|
2,006
|
EBITDA
1 |
242.8
|
292.7
|
248.5
|
164.6
|
42.19
|
30.91
|
EBIT
1 |
184.3
|
227.9
|
174.3
|
94.81
|
-15.51
|
-18.91
|
Operating Margin
|
13.99%
|
12.45%
|
8.2%
|
3.65%
|
-0.67%
|
-0.94%
|
Earnings before Tax (EBT)
1 |
156.4
|
186.2
|
108.1
|
-24.11
|
-191.7
|
-192.5
|
Net income
1 |
94.16
|
110.4
|
57.56
|
-49.51
|
-154.4
|
-158.6
|
Net margin
|
7.15%
|
6.03%
|
2.71%
|
-1.9%
|
-6.69%
|
-7.9%
|
EPS
2 |
0.4900
|
0.5600
|
0.2900
|
-0.2524
|
-0.7940
|
-0.8200
|
Free Cash Flow
1 |
-260.6
|
-143.4
|
-304.2
|
-186.9
|
240.9
|
386.3
|
FCF margin
|
-19.78%
|
-7.83%
|
-14.31%
|
-7.19%
|
10.44%
|
19.26%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
571.07%
|
1,249.88%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
0.0800
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/25/19
|
4/29/20
|
4/29/21
|
4/25/22
|
4/26/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
371
|
737
|
1,114
|
1,011
|
771
|
Net Cash position
1 |
14.9
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.269
x
|
2.965
x
|
6.767
x
|
23.95
x
|
24.95
x
|
Free Cash Flow
1 |
-261
|
-143
|
-304
|
-187
|
241
|
386
|
ROE (net income / shareholders' equity)
|
8.86%
|
8.77%
|
4.79%
|
-2.16%
|
-11.8%
|
-11.2%
|
ROA (Net income/ Total Assets)
|
5.55%
|
5.1%
|
3.15%
|
1.45%
|
-0.24%
|
-0.32%
|
Assets
1 |
1,697
|
2,166
|
1,826
|
-3,425
|
65,654
|
48,972
|
Book Value Per Share
2 |
7.410
|
7.510
|
8.310
|
7.960
|
7.260
|
6.320
|
Cash Flow per Share
2 |
3.430
|
2.560
|
3.340
|
2.410
|
2.040
|
1.450
|
Capex
1 |
119
|
96.5
|
128
|
60.2
|
54.6
|
40.8
|
Capex / Sales
|
9%
|
5.27%
|
6.01%
|
2.32%
|
2.37%
|
2.04%
|
Announcement Date
|
4/25/19
|
4/29/20
|
4/29/21
|
4/25/22
|
4/26/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| -36.25% | 185M | | -3.25% | 9.41B | | -0.02% | 1.44B | | -6.75% | 1.38B | | -13.57% | 1.11B | | -16.87% | 873M | | -1.34% | 463M | | +3.28% | 440M | | -21.49% | 348M | | -3.34% | 211M |
Medical Equipment Wholesale
|